Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new research.
By linking a national vascular registry with medical data records in Medicare claims for patients who underwent endovascular abdominal aortic aneurysm repair, a team of researchers from across the country was able to identify which devices posed the most risk for reintervention.
MBA candidates in the first cohort of Cornell's new BioEntrepreneurship Initiative will collaborate with doctoral researchers in the life sciences across Cornell. The program is designed to develop startup leaders and foster innovation in the life sciences.
A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine seeks to provide a fast and accurate diagnosis of Kaposi sarcoma, a common yet difficult-to-detect cancer that often signals the presence of HIV infection.
The World Health Organization has selected the Division of Nutritional Sciences to lead systematic reviews and training supporting the development of WHO guidelines and research networks.
Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Six Cornell faculty members from three different colleges will work together to improve epidemiological models of infectious disease, including by better incorporating human behavior into the models, using a $1 million grant from the National Science Foundation.
Celebrating graduation and each other, students in the Executive Master of Health Administration and Executive Master of Public Administration programs at the Cornell Jeb E. Brooks School of Public Policy received diplomas at a joyful ceremony in Willard Straight Hall.
Neurons that sense pain protect the gut from inflammation and associated tissue damage by regulating the microbial community living in the intestines, according to a study from researchers at Weill Cornell Medicine.
A highly innovative method using the latest technology opens myriad new avenues for research, for understanding the biology behind COVID-19, and for identifying new treatments that target protein binding sites.